Moderna Suing Pfizer For COVID-19 Vaccine Patent Infringement
Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German regional court Friday in connection with the two companies’ COVID-19 vaccine, Moderna announced.
Moderna alleges Pfizer and BioNTech’s Comirnaty vaccine breaches its mRNA technology patents submitted between 2010 and 2016. It claims they developed their vaccine by copying the technology Moderna used to make its mRNA COVID-19 vaccine, Spikevax.
“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic,” Moderna CEO Stéphane Bancel said. “This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck.”
Moderna insisted it is not trying to remove Comirnaty from the market or win damages for actions taken before March 8, 2022. The company said it recognized “the need to ensure continued access to these lifesaving vaccines.”
Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact email@example.com.